Chemistry Wealth Management LLC Has $2.13 Million Stock Holdings in Elevance Health, Inc. (NYSE:ELV)

Chemistry Wealth Management LLC lessened its stake in Elevance Health, Inc. (NYSE:ELV - Free Report) by 15.1% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,766 shares of the company's stock after selling 1,027 shares during the quarter. Chemistry Wealth Management LLC's holdings in Elevance Health were worth $2,127,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Raelipskie Partnership acquired a new position in Elevance Health during the 3rd quarter worth approximately $26,000. PSI Advisors LLC bought a new position in Elevance Health in the third quarter valued at $27,000. Eastern Bank acquired a new stake in Elevance Health in the 3rd quarter valued at $31,000. Dunhill Financial LLC lifted its position in Elevance Health by 57.8% during the 3rd quarter. Dunhill Financial LLC now owns 71 shares of the company's stock worth $37,000 after buying an additional 26 shares in the last quarter. Finally, Peterson Financial Group Inc. acquired a new position in shares of Elevance Health during the 3rd quarter worth about $44,000. Institutional investors own 89.24% of the company's stock.

Analysts Set New Price Targets

A number of research analysts have weighed in on the company. StockNews.com upgraded Elevance Health from a "hold" rating to a "buy" rating in a research note on Friday. Truist Financial lowered their target price on shares of Elevance Health from $520.00 to $480.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Wells Fargo & Company cut their price target on shares of Elevance Health from $593.00 to $495.00 and set an "overweight" rating for the company in a research note on Monday, November 4th. TD Cowen decreased their price objective on shares of Elevance Health from $589.00 to $484.00 and set a "buy" rating for the company in a research report on Monday, October 21st. Finally, Argus cut shares of Elevance Health from a "buy" rating to a "hold" rating in a report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, Elevance Health currently has an average rating of "Moderate Buy" and an average target price of $536.53.

Elevance Health Price Performance

Shares of ELV traded down $1.00 during trading hours on Friday, hitting $384.26. 2,696,400 shares of the company were exchanged, compared to its average volume of 1,457,754. The company has a quick ratio of 1.50, a current ratio of 1.50 and a debt-to-equity ratio of 0.56. Elevance Health, Inc. has a fifty-two week low of $362.21 and a fifty-two week high of $567.26. The company has a market cap of $89.12 billion, a price-to-earnings ratio of 14.01, a P/E/G ratio of 1.08 and a beta of 0.84. The firm's fifty day moving average is $388.02 and its 200 day moving average is $467.11.

Elevance Health (NYSE:ELV - Get Free Report) last released its earnings results on Thursday, October 17th. The company reported $8.37 EPS for the quarter, missing the consensus estimate of $9.66 by ($1.29). Elevance Health had a net margin of 3.68% and a return on equity of 19.56%. The firm had revenue of $44.72 billion during the quarter, compared to the consensus estimate of $43.47 billion. During the same period in the prior year, the business earned $8.99 earnings per share. Elevance Health's quarterly revenue was up 5.3% compared to the same quarter last year. On average, equities analysts anticipate that Elevance Health, Inc. will post 32.96 earnings per share for the current fiscal year.

About Elevance Health

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.